Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Menopausal Vasomotor Symptoms, Atrophic Vaginitis/Kraurosis Vulvae
Dose: Tablet – 0.3 mg
Frequency: by mouth once daily in either continuous daily regimen or cyclic regimen (25 days on, 5 days off)
Note: Adjusted as needed; use lowest dose that control symptoms; may be given daily if medical assessment warrants it
Indication: Female Hypogonadism
Dose: Tablet – 0.3-0.625 mg
Frequency: by mouth once daily in cyclic regimen (3 weeks on, 1 week off)
Note: May be titrated every 6-12 months; adjusted as needed; add progestin treatment should be added to maintain bone mineral density once skeletal maturity achieved

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Not applicable – No approved pediatric dosage available
Note: No approved pediatric dosage available
Administration
  • Can be taken with or without food
  • Take at same time daily
Side Effect

Drug Interaction

Drug NameRisk Factors
Rifampicin, Barbiturates
Increase rate of metabolism
Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban)
May reduce the efficacy

Disease Interaction

Disease NameRisk Factors
Severe Liver Impairment
Can cause liver toxicity
Breast Carcinoma
Can stimulate cancer growth

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool (below 30°C) and dry place, protected from light and moisture.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.